Search company, investor...

Predict your next investment

Venture Capital
sparta-llc.com

Investments

3

Portfolio Exits

1

About SPARTA Capital Partners

SPARTA Capital Partners is focused on providing capital and expertise to a select group of industrial / manufacturing based companies. SPARTA is owned and operated by Roland J. Parker and Richard M. Armbrust. SPARTA's business strategy is focused on helping business owners achieve desired goals by providing capital and business experience. SPARTA can help facilitate a recapitalization, a turnaround, an owner retirement strategy, or a management buyout. SPARTA has chosen to finance each transaction on a deal by deal basis. This provides each investor with more choices over their portfolio, and it provides the current owner / management team with an investor group whose interests are more closely aligned with theirs.

Headquarters Location

United States

Want to inform investors similar to SPARTA Capital Partners about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

SPARTA Capital Partners Investments

3 Investments

SPARTA Capital Partners has made 3 investments. Their latest investment was in GFBiochemicals as part of their Series A on May 5, 2022.

CBI Logo

SPARTA Capital Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

5/9/2022

Series A

GFBiochemicals

$15.84M

Yes

2

2/8/2022

Series A

Subscribe to see more

$99M

Subscribe to see more

10

1/28/2013

Series D - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

5/9/2022

2/8/2022

1/28/2013

Round

Series A

Series A

Series D - II

Company

GFBiochemicals

Subscribe to see more

Subscribe to see more

Amount

$15.84M

$99M

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

10

10

SPARTA Capital Partners Portfolio Exits

1 Portfolio Exit

SPARTA Capital Partners has 1 portfolio exit. Their latest portfolio exit was Ocular Therapeutix on July 25, 2014.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

7/25/2014

IPO

$99M

Public

1

Date

7/25/2014

Exit

IPO

Companies

Valuation

$99M

Acquirer

Public

Sources

1

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.